IMKTA Stock Recent News
IMKTA LATEST HEADLINES
Ingles Markets' H2/FY2023 results show solid performance, as margins have been sustained at a great level with mostly stable revenues. After my previous write-up, the stock has remained relatively flat despite earnings above my expectations. The stock still seems to have a great undervaluation, as my DCF model estimates a very good amount of upside.
Ingles Markets is a United States-based company operating supermarkets as well as pharmacies and fuel stations. The company has maintained minimally growing revenues with steady margin, although the company's operating margin is currently above a sustainable level. Ingles Markets is a low-risk stock, as supermarket revenues are highly recession-proof.
IMKTA is a regional grocer that has seen a new level of operating quality since the pandemic. The company won't be growing store count at all, but you don't need that in order to make money from the stock right now.
Recently, shares of Ingles Markets came under pressure, in large part because of bottom line weakness. This may deter some investors from buying into the retail chain, but shares still look cheap even if we assume this weakness will continue.
Ingles Markets has been a solid play relative to the broader market, with sales and cash flows increasing. Profits have struggled a bit, but the overall health of the company looks to be intact.
Ingles Markets continues to fare well compared to the broader market, but this doesn't change the fact that the business appears robust. Growth continues, but we have seen a bit of weakness on the bottom line.
Ingles Markets has continued its remarkable progress into the current fiscal year. Investors have been beneficiaries of this strength, with a stock that has outperformed the broader market recently.
Ingles Markets, Incorporated (NASDAQ:IMKTA) is an American supermarket chain that operates approximately 200 supermarkets in six southeastern states.
As investors await a key monetary policy announcement from the Federal Reserve later this week, U.S. market indexes recorded a mixed performance on Tuesday.
March Quarter +40% YoY EPS, +16.3% YoY net sales. 8.9x P/E on FY2022 estimates.